Health 22 May 2020 Invex raises $26m for clinical trials Bookmark Save articles for future reference. Subscribe to BN Log In Share to Facebook X LinkedIn Invex Therapeutics has received a $5 million investment from Andrew Forrest's Tattarang as part of a share placement, with the proceeds to go towards the company's research into neurological diseases.
Technology, Innovation & Science 05 Jul 2019 New WA ASX listing closes up 169% Bookmark Save articles for future reference. Subscribe to BN Log In Share to Facebook X LinkedIn Invex Therapeutics has become just the third WA-based company to list on the ASX this year, with Minderoo Group its largest shareholder.
